Richard A Miller

Richard A Miller is a co-founder, the president, and chief executive officer of Corvus Pharmaceuticals, a clinical-stage biopharmaceutical company focused on the development of novel agents. Previously, he co-founded Pharmacyclics and served the same company as the chief executive officer. At Pharmacyclics, he led the initial discovery and development efforts for ibrutinib.

Prior to co-founding Pharmacyclics, Miller co-founded IDEC and held various leadership roles as vice president and director at the same company. He has also founded other private and public biotech companies.

Miller holds a Doctor of Medicine degree, summa cum laude, from the State University of New York Medical School and is currently Adjunct Clinical Professor of Medicine at Stanford University Medical Center.

Richard A Miller is the Co-Founder, President, & CEO at Corvus Pharmaceuticals, based in United States, North America. With a background in Biotechnology, Richard A Miller has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.